Peripheral nerve structure and function in long-term galactosemic dogs: Morphometric and electron microscopic analyses

Acta Neuropathologica

Volumn 97, Issue 4, 1999, Pages 369-376

  Sugimoto, Kazuhiro ^a   Kasahara, Toshiharu ^b   Yonezawa, Hidetoshi ^b   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Ono Safety Research Institute   (Japan)

Author keywords

Dog; Galactose; Nerve conduction; Neuropathy; Pathology

Indexed keywords

CELLULOSE; GALACTOSE; POLYOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; AUTONOMIC GANGLION; CELL SIZE; CONTROLLED STUDY; DEMYELINATION; DIET; DOG; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; GALACTOSEMIA; GLUCOSE BLOOD LEVEL; MALE; MORPHOMETRICS; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; MYELINATED NERVE; NERVE; NERVE CELL; NERVE CONDUCTION; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REMYELINIZATION; SENSORY NERVE CONDUCTION; SPECIES DIFFERENCE;

ANIMALS; AXONS; DOGS; EVOKED POTENTIALS; GALACTOSEMIAS; MALE; MICROSCOPY, ELECTRON; MYELIN SHEATH; NERVE FIBERS; NEURAL CONDUCTION; PERIPHERAL NERVES; TIME;

EID: 0032972816     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010051000     Document Type: Article

References (43)

1. Akagi Y, Kobayashi T, Takahashi Y, Tsuzuki S, Kubo E, Takayanagi K, Mori K, Kasahara T, Yonezawa H (1997) Effect of an aldose reductase inhibitor, ONO2235, on galactosemic retinopathy in dogs [abstract]. Proc US-Japan aldose reductase workshop 1:27
2. Appenzeller O, Richardson EP (1966) The sympathetic chain in patients with diabetic and alcoholic polyneuropathy. Neurology 16: 1205-1209
3. +-ATPase activity in galactose-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes 39:663-666
4. Cogan DG, Kinoshita JH, Kador PF, Robison WG, Datilies MB, Cobo LM, Kupfer C (1984) Aldose reductase and complications of diabetes. Ann Intern Med 101:82-91
5. Eades DM, Williamson JR, Sherman WR (1989) Rapid analysis of sorbitol, galactitol, mannitol and myoinositol mixtures from biological sources. J Chromatogr 490: 1-8
6. Engerman RL, Kern TS (1984) Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33:97-100
7. Engerman RL, Kern TS (1993) Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 42:820-825
8. Engerman RL, Kern TS (1995) Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. Arch Ophthalmol 113:355-358
9. Engerman RL, Kern TS, Larson ME (1990) Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia. Metabolism 39:638-640
10. Engerman RL, Kern TS, Larson ME (1994) Nerve conduction and aldose reductase inhibition during 5 years of diabetes and galactosemia in dogs. Diabetologia 37:141-144
11. Forcier NJ, Mizisin AP, Rimmer MA, Powell HC (1991) Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropathol Exp Neurol 50:235-255
12. Gabbay KH (1973) The sorbitol pathway and the complications of diabetes. N Engl J Med 288:831-836
13. Gabbay KH, Snider JJ (1972) Nerve conduction defect in galactose-fed rats. Diabetes 21:295-300
14. Greene DA, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606
15. Heesom AE, Hibberd ML, Millward A, Demaine AG (1997) Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 46:287-291
16. Jaspan J, Maselli R, Herold K, Bartkus C (1983) Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function. Lancet II:758-762
17. Kador PF, Takahashi Y, Wyman M, Ferris F (1995) Diabetes-like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 113:352-354
18. Ko BC-B, Lam KS.L. Watt NM-S, Chung SS-M (1995) An (A-C)n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 44:727-732
19. McManis PG, Low PA, Yao JK (1986) Relationship between nerve blood flow and intercapillary distance in peripheral nerve edema. Am J Physiol 251:E92-E97
20. Mizisin AP, Powell HC (1993) Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication. J Neuropathol Exp Neurol 52:78-86
21. Mizisin AP, Powell HC, Myers RR (1986) Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor. J Neurol Sci 74:35-43
22. Mizisin AP, Calcutt NA, Distefano PS, Acheson A, Longo FM (1997) Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes 46:647-652
23. Myers RR, Powell HC (1984) Galactose neuropathy: impact of chronic endoneurial edema on nerve blood flow. Ann Neurol 16:587-594
24. Nicolucci A, Carinici F, Graepel JG, Hohman TC, Ferris F, Lachin JM (1996) The efficacy of tolrestat in the treatment of diabetic peripheral neuropathy. Diabetes Care 19:1091-1096
25. Nishimura C, Saito T, Omori Y, Tanimoto T (1994) High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients. Diabetologia 37:328-330
26. Ohnishi A, Tanimoto T, Nagaki J, Jinnouchi T, Ishizu H (1996) Relationship between erythrocyte aldose reductase level and diabetic complications among 98 NIDDM patients. J Jpn Diab Soc 39:783-788
27. Pedersen MM, Christiansen JS, Mogensen CE (1991) Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 months of aldose reductase inhibition. Diabetes 40:527-531
28. Powell HC, Myers RR (1983) Schwann cell changes and demyelination in chronic galactose neuropathy. Muscle Nerve 6: 218-227
29. Robison WG, Kador PF, Kinoshita JH (1983) Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science 221:1177-1179
30. Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG (1989) Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozotocin-induced diabetic rats. Diabetes 38:569-579
31. Schmidt RE, Plurad SB, Modert CW (1983) Neuroaxonal dystrophy in the autonomic ganglia of aged rats. J Neuropathol Exp Neurol 42:376-390
32. Schmidt RE, Plurad SB, Parvin CA, Roth KA (1993) Effect of diabetes and aging on human sympathetic autonomic ganglia. Am J Pathol 143:43-453
33. Sharma AK, Thomas PK, Baker RW (1976) Peripheral nerve abnormalities related to galactose administration in rats. J Neurol Neurosurg Psychiatry 39:794-802
34. Sima AAF, Bril V, Nathaniel V, McEwen TAJ, Brown MB, Lattimer SA, Greene DA (1988) Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 319:548-555
35. Varma SD, Kinoshita JH (1974) The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res 19:577-582
36. Vita G, Santoro M, Trombetta G, Leonardi L, Messina C (1992) A computer-assisted automatic method for myelinated nerve fiber morphometry. Acta Neurol Scand 85:18-22
37. Whitely SJ, Tomlinson DR (1985) Motor nerve conduction velocity, and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes. Exp Neurol 89:314-321
38. Willars GB, Calcutt NA, Tomlinson DR (1991) Nerve conduction velocity and axonal transport of 6-phosphofructokinase activity in galactose-fed rats. J Neurol Sci 104:46-51
39. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamaura T, Nyengaard JR, VanDenEnden M, Kilo C, Tilton RG (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813
40. Yagihashi S (1995) Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev 11:193-225
41. Yagihashi S (1997) Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models. J Periph Nerv Syst 2: 113-132
42. Yagihashi S, Sima AAF (1986) Neuroaxonal and dendritic dystrophy in diabetic autonomic neuropathy. Classification and topographic distribution in the BB-rat. J Neuropathol Exp Neurol 45:545-565
43. Yagihashi S, Yamagishi S-I, Wada R, Sugimoto K, Baba M, Wong H-G, Fujimoto J, Nishimura C, Kokai Y (1996) Galactosemic neuropathy in transgenic mice for human aldose reductase. Diabetes 45:56-59